Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Treatment of Skin Ulcers With Microcyn® Technology

[at noodls] – PETALUMA, Calif., Feb. 25, 2013 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a commercial healthcare company that designs, produces and markets innovative, safe and effective drugs, … more

View todays social media effects on OCLS

View the latest stocks trending across Twitter. Click to view dashboard

See who Oculus is hiring next, click here to view